Qualitative Review of Serotonin Syndrome, Ecstasy (MDMA) and the use of Other Serotonergic Substances: Hierarchy of Risk
@article{Silins2007QualitativeRO, title={Qualitative Review of Serotonin Syndrome, Ecstasy (MDMA) and the use of Other Serotonergic Substances: Hierarchy of Risk}, author={E. Silins and J. Copeland and P. Dillon}, journal={Australian and New Zealand Journal of Psychiatry}, year={2007}, volume={41}, pages={649 - 655} }
Growth of the antidepressant market and widespread use of the illicit drug ecstasy (methylenedioxymethamphetamine; MDMA) creates a need to delineate the potential harms associated with the concomitant use of ecstasy and serotonergic pharmaceutical drugs. One such harm is serotonin syndrome. The study aimed to synthesize the risk of serotonin syndrome associated with the concomitant use of ecstasy and other serotonergic substances in a clinically relevant hierarchy for psychiatrists and other… CONTINUE READING
Tables and Topics from this paper
Tables
57 Citations
Ecstasy use and serotonin syndrome: a neglected danger to adolescents and young adults prescribed selective serotonin reuptake inhibitors
- Medicine
- International journal of adolescent medicine and health
- 2013
- 8
Patterns and harms of pharmaceutical drug use among ecstasy users in Australia.
- History, Psychology
- Adicciones
- 2009
- 2
Serotonin toxicity involving MDMA (ecstasy) and moclobemide.
- Medicine
- Forensic science international
- 2012
- 29
Death of a female cocaine user due to the serotonin syndrome following moclobemide-venlafaxine overdose.
- Medicine
- Forensic science international
- 2009
- 15
Cortisol and 3,4-Methylenedioxymethamphetamine: Neurohormonal Aspects of Bioenergetic Stress in Ecstasy Users
- Psychology, Medicine
- Neuropsychobiology
- 2009
- 63
Guidance on the clinical management of acute and chronic harms of club drugs and novel psychoactive substances.
- Medicine
- 2015
- 52
- PDF
MDMA-Associated Liver Toxicity: Pathophysiology, Management, and Current State of Knowledge.
- Medicine
- AACN advanced critical care
- 2019
References
SHOWING 1-10 OF 83 REFERENCES
The confounding problem of polydrug use in recreational ecstasy/MDMA users: a brief overview
- Psychology, Medicine
- Journal of psychopharmacology
- 2006
- 169
Recreational Ecstasy/MDMA, the serotonin syndrome, and serotonergic neurotoxicity
- Psychology, Medicine
- Pharmacology Biochemistry and Behavior
- 2002
- 262
- PDF
Neurotoxicity of methylenedioxyamphetamines (MDMA; ecstasy) in humans: how strong is the evidence for persistent brain damage?
- Psychology, Medicine
- Addiction
- 2006
- 152
A bitter pill. Overview of ecstasy (MDMA, MDA) related fatalities
- Medicine
- Psychopharmacology
- 2003
- 169
- PDF
The serotonin uptake inhibitor citalopram reduces acute cardiovascular and vegetative effects of 3, 4-methylenedioxymethamphetamine (‘Ecstasy’) in healthy volunteers
- Psychology, Medicine
- Journal of psychopharmacology
- 2000
- 132
- PDF
Acute Psychological Effects of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”) are Attenuated by the Serotonin Uptake Inhibitor Citalopram
- Psychology, Medicine
- Neuropsychopharmacology
- 2000
- 188
- PDF